InsidersTradesSigma
Track the Sprint Bioscience AB stock price and the full directors' dealings record of the company, a listed equity based in Finland. Shares are listed on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Sprint Bioscience AB has recorded 2 public disclosures. Market capitalisation: €395.7m. The latest transaction was disclosed on 11 December 2025 (Purchase). Among the most active insiders: Björn Sjöstrand. All data is free.
2
Insider Decl.
n/a
Thresholds
€24,019
2 ops.
Buy Volume
n/a
n/a
Sell Volume
19Σ signal
Fundamental score
Ranked 6 of 29,064 companies
96.7
score / 100
Value96
Quality98
FCF yld24%
Earn yld26%
EV/EBITDA3.8x
ROE154%
Gross mgn92%
Net mgn55%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 11 December 2025
Declarations2 total
30,000 shares@ €0.13320.0011% mcap16.6% of flowAktieISIN SE0006343745FI:A003U606-1
333,520 shares@ €0.060.0055% mcap83.4% of flowBTA (betald tecknad aktie)ISIN SE0016609804FI:A003N847-2
2 of 2 declarations
关于 Sprint Bioscience AB
Sprint Bioscience AB 是一家瑞典公司，专注于开发癌症治疗药物。该公司专门从事新型靶向疗法的发现和开发。